(19)
(11) EP 3 632 372 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
29.05.2024 Bulletin 2024/22

(45) Mention of the grant of the patent:
06.03.2024 Bulletin 2024/10

(21) Application number: 19211117.7

(22) Date of filing: 19.08.2014
(51) International Patent Classification (IPC): 
A61D 7/04(2006.01)
A61M 15/08(2006.01)
A61M 16/20(2006.01)
A46B 11/00(2006.01)
 A61M 15/00(2006.01)
A61M 16/08(2006.01)
B05B 11/00(2023.01)
(52) Cooperative Patent Classification (CPC):
A46B 11/002; A61M 15/0086; A61M 15/009; A61M 2205/583; A61M 2250/00; A61M 15/0018; A61M 15/0073; A61M 2205/581; A61M 15/0013; A61M 15/0093; A61M 15/0096; B05B 7/0012; B05B 11/0038; A61D 7/04; A61M 15/08; B05B 11/1056; B05B 11/1091

(54)

INHALER

INHALATOR

INHALATEUR

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.08.2013 EP 13004113

(43) Date of publication of application:
08.04.2020 Bulletin 2020/15

(62) Application number of the earlier application in accordance with Art. 76 EPC:
14766657.2 / 3035887

(73) Proprietor: Boehringer Ingelheim Vetmedica GmbH
55216 Ingelheim am Rhein (DE)

(72) Inventors:
  • RAHMEL, Marcus Rainer
    55216 Ingelheim am Rhein (DE)
  • WACHTEL, Herbert
    55216 Ingelheim am Rhein (DE)
  • ENDERT, Guido
    50769 Köln (DE)
  • CHRIST, Alexander
    50769 Köln (DE)
  • WERGEN, Horst
    50769 Köln (DE)

(74) Representative: Von Rohr Patentanwälte Partnerschaft mbB 
Rüttenscheider Straße 62
45130 Essen
45130 Essen (DE)


(56) References cited: : 
EP-A1- 0 134 847
US-B1- 6 435 177
 WO-A1-2005/079997
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).